These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31336138)
1. Targeting apolipoprotein E for treating Alzheimer's disease. Bales KR; Paul SM Neurosci Lett; 2019 Sep; 709():134366. PubMed ID: 31336138 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. Koffie RM; Hashimoto T; Tai HC; Kay KR; Serrano-Pozo A; Joyner D; Hou S; Kopeikina KJ; Frosch MP; Lee VM; Holtzman DM; Hyman BT; Spires-Jones TL Brain; 2012 Jul; 135(Pt 7):2155-68. PubMed ID: 22637583 [TBL] [Abstract][Full Text] [Related]
3. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models. Zhao L; Gottesdiener AJ; Parmar M; Li M; Kaminsky SM; Chiuchiolo MJ; Sondhi D; Sullivan PM; Holtzman DM; Crystal RG; Paul SM Neurobiol Aging; 2016 Aug; 44():159-172. PubMed ID: 27318144 [TBL] [Abstract][Full Text] [Related]
4. Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer's disease in an induced neuron. Kim H; Yoo J; Shin J; Chang Y; Jung J; Jo DG; Kim J; Jang W; Lengner CJ; Kim BS; Kim J Brain; 2017 Aug; 140(8):2193-2209. PubMed ID: 28899010 [TBL] [Abstract][Full Text] [Related]
5. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. Huang Y Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952 [TBL] [Abstract][Full Text] [Related]
6. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease. Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531 [TBL] [Abstract][Full Text] [Related]
7. Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease. Ishii K; Tamaoka A; Mizusawa H; Shoji S; Ohtake T; Fraser PE; Takahashi H; Tsuji S; Gearing M; Mizutani T; Yamada S; Kato M; St George-Hyslop PH; Mirra SS; Mori H Brain Res; 1997 Feb; 748(1-2):250-2. PubMed ID: 9067471 [TBL] [Abstract][Full Text] [Related]
8. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain. Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele. Padayachee ER; Zetterberg H; Portelius E; Borén J; Molinuevo JL; Andreasen N; Cukalevski R; Linse S; Blennow K; Andreasson U Brain Res; 2016 Nov; 1651():11-16. PubMed ID: 27653981 [TBL] [Abstract][Full Text] [Related]
10. Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain. Rohn TT; Catlin LW; Coonse KG; Habig JW Brain Res; 2012 Sep; 1475():106-15. PubMed ID: 22902767 [TBL] [Abstract][Full Text] [Related]
11. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Bales KR Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease. Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024 [TBL] [Abstract][Full Text] [Related]
13. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease. Saul A; Wirths O Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512 [TBL] [Abstract][Full Text] [Related]
14. The genetics of late-onset Alzheimer's disease. Myers AJ; Goate AM Curr Opin Neurol; 2001 Aug; 14(4):433-40. PubMed ID: 11470958 [TBL] [Abstract][Full Text] [Related]
15. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease. Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683 [TBL] [Abstract][Full Text] [Related]